Genital Diseases, Female  >>  Suprefact (buserelin acetate)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Suprefact (buserelin acetate) / Sanofi
NCT00749853: Efficacy of Ovarian Stimulation Based on FSHR Genotype Status

Suspended
3
165
Europe
follicle stimulating hormone, buserelin, r-hFSH, r-hLH, buserelin, r-hFSH, HCG
Medical University of Vienna
Sterility
05/15
06/15

Download Options